Literature DB >> 21889982

Enhanced GABAergic network and receptor function in pediatric cortical dysplasia Type IIB compared with Tuberous Sclerosis Complex.

Carlos Cepeda1, Véronique M André, Jason S Hauptman, Irene Yamazaki, My N Huynh, Julia W Chang, Jane Y Chen, Robin S Fisher, Harry V Vinters, Michael S Levine, Gary W Mathern.   

Abstract

Tuberous Sclerosis Complex (TSC) and cortical dysplasia Type IIB (CDIIB) share histopathologic features that suggest similar epileptogenic mechanisms. This study compared the morphological and electrophysiological properties of cortical cells in tissue from pediatric TSC (n=20) and CDIIB (n=20) patients using whole-cell patch clamp recordings and biocytin staining. Cell types were normal-appearing and dysmorphic-cytomegalic pyramidal neurons, interneurons, and giant/balloon cells, including intermediate neuronal-glial cells. In the cortical mantle, giant/balloon cells occurred more frequently in TSC than in CDIIB cases, whereas cytomegalic pyramidal neurons were found more frequently in CDIIB. Cell morphology and membrane properties were similar in TSC and CDIIB cases. Except for giant/balloon and intermediate cells, all neuronal cell types fired action potentials and displayed spontaneous postsynaptic currents. However, the frequency of spontaneous glutamatergic postsynaptic currents in normal pyramidal neurons and interneurons was significantly lower in CDIIB compared with TSC cases and the GABAergic activity was higher in all neuronal cell types in CDIIB. Further, acutely dissociated pyramidal neurons displayed higher sensitivity to exogenous application of GABA in CDIIB compared with TSC cases. These results indicate that, in spite of similar histopathologic features and basic cell membrane properties, TSC and CDIIB display differences in the topography of abnormal cells, excitatory and inhibitory synaptic network properties, and GABA(A) receptor sensitivity. These differences support the notion that the mechanisms of epileptogenesis could differ in patients with TSC and CDIIB. Consequently, pharmacologic therapies should take these findings into consideration.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21889982      PMCID: PMC3225687          DOI: 10.1016/j.nbd.2011.08.015

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  55 in total

1.  Morphological and electrophysiological characterization of abnormal cell types in pediatric cortical dysplasia.

Authors:  Carlos Cepeda; Raymond S Hurst; Jorge Flores-Hernández; Elizabeth Hernández-Echeagaray; Gloria J Klapstein; Marea K Boylan; Christopher R Calvert; Emily L Jocoy; Oanh K Nguyen; Véronique M André; Harry V Vinters; Marjorie A Ariano; Michael S Levine; Gary W Mathern
Journal:  J Neurosci Res       Date:  2003-05-15       Impact factor: 4.164

2.  NMDA receptor alterations in neurons from pediatric cortical dysplasia tissue.

Authors:  Véronique M André; Jorge Flores-Hernández; Carlos Cepeda; Amaal J Starling; Snow Nguyen; Mary Kay Lobo; Harry V Vinters; Michael S Levine; Gary W Mathern
Journal:  Cereb Cortex       Date:  2004-03-28       Impact factor: 5.357

3.  Differential expression of glutamate and GABA-A receptor subunit mRNA in cortical dysplasia.

Authors:  P B Crino; A C Duhaime; G Baltuch; R White
Journal:  Neurology       Date:  2001-04-10       Impact factor: 9.910

4.  Epileptogenicity of focal malformations due to abnormal cortical development: direct electrocorticographic-histopathologic correlations.

Authors:  Kanokwan Boonyapisit; Imad Najm; George Klem; Zhong Ying; Candice Burrier; Eric LaPresto; Dileep Nair; William Bingaman; Richard Prayson; Hans Lüders
Journal:  Epilepsia       Date:  2003-01       Impact factor: 5.864

5.  Malformations of cortical development with balloon cells: clinical and radiologic correlates.

Authors:  M T Mackay; L E Becker; S H Chuang; H Otsubo; N A Chuang; J Rutka; B Ben-Zeev; O C Snead; S K Weiss
Journal:  Neurology       Date:  2003-02-25       Impact factor: 9.910

6.  mTOR cascade activation distinguishes tubers from focal cortical dysplasia.

Authors:  Marianna Baybis; Jia Yu; Allana Lee; Jeff A Golden; Howard Weiner; Guy McKhann; Eleonora Aronica; Peter B Crino
Journal:  Ann Neurol       Date:  2004-10       Impact factor: 10.422

7.  Insulin signaling pathways in cortical dysplasia and TSC-tubers: tissue microarray analysis.

Authors:  Hajime Miyata; Alexander C Y Chiang; Harry V Vinters
Journal:  Ann Neurol       Date:  2004-10       Impact factor: 10.422

8.  Immature neurons and GABA networks may contribute to epileptogenesis in pediatric cortical dysplasia.

Authors:  Carlos Cepeda; Véronique M André; Nanping Wu; Irene Yamazaki; Besim Uzgil; Harry V Vinters; Michael S Levine; Gary W Mathern
Journal:  Epilepsia       Date:  2007       Impact factor: 5.864

9.  Focal dysplasia of the cerebral cortex in epilepsy.

Authors:  D C Taylor; M A Falconer; C J Bruton; J A Corsellis
Journal:  J Neurol Neurosurg Psychiatry       Date:  1971-08       Impact factor: 10.154

10.  Cytomegalic interneurons: a new abnormal cell type in severe pediatric cortical dysplasia.

Authors:  Véronique M André; Nanping Wu; Irene Yamazaki; Snow T Nguyen; Robin S Fisher; Harry V Vinters; Gary W Mathern; Michael S Levine; Carlos Cepeda
Journal:  J Neuropathol Exp Neurol       Date:  2007-06       Impact factor: 3.685

View more
  17 in total

1.  RHEB/mTOR hyperactivity causes cortical malformations and epileptic seizures through increased axonal connectivity.

Authors:  Martina Proietti Onori; Linda M C Koene; Carmen B Schäfer; Mark Nellist; Marcel de Brito van Velze; Zhenyu Gao; Ype Elgersma; Geeske M van Woerden
Journal:  PLoS Biol       Date:  2021-05-26       Impact factor: 8.029

2.  Targeted disruption of layer 4 during development increases GABAA receptor neurotransmission in the neocortex.

Authors:  J Abbah; Maria F M Braga; S L Juliano
Journal:  J Neurophysiol       Date:  2013-10-23       Impact factor: 2.714

3.  Pacemaker GABA synaptic activity may contribute to network synchronization in pediatric cortical dysplasia.

Authors:  Carlos Cepeda; Jane Y Chen; Joyce Y Wu; Robin S Fisher; Harry V Vinters; Gary W Mathern; Michael S Levine
Journal:  Neurobiol Dis       Date:  2013-10-10       Impact factor: 5.996

Review 4.  Basic mechanisms of epileptogenesis in pediatric cortical dysplasia.

Authors:  Sara Abdijadid; Gary W Mathern; Michael S Levine; Carlos Cepeda
Journal:  CNS Neurosci Ther       Date:  2014-11-18       Impact factor: 5.243

5.  BRAFV600E expression in neural progenitors results in a hyperexcitable phenotype in neocortical pyramidal neurons.

Authors:  Roman U Goz; Gülcan Akgül; Joseph J LoTurco
Journal:  J Neurophysiol       Date:  2020-05-13       Impact factor: 2.714

6.  Rapamycin has a beneficial effect on controlling epilepsy in children with tuberous sclerosis complex: results of 7 children from a cohort of 86.

Authors:  Mehmet Canpolat; Huseyin Per; Hakan Gumus; Ali Yikilmaz; Ekrem Unal; Turkan Patiroglu; Levent Cinar; Ali Kurtsoy; Sefer Kumandas
Journal:  Childs Nerv Syst       Date:  2013-06-07       Impact factor: 1.475

Review 7.  Seizures and gliomas--towards a single therapeutic approach.

Authors:  Gilles Huberfeld; Charles J Vecht
Journal:  Nat Rev Neurol       Date:  2016-03-11       Impact factor: 42.937

Review 8.  WONOEP appraisal: Development of epilepsy biomarkers-What we can learn from our patients?

Authors:  Sergiusz Jozwiak; Albert Becker; Carlos Cepeda; Jerome Engel; Vadym Gnatkovsky; Gilles Huberfeld; Mehmet Kaya; Katja Kobow; Michele Simonato; Jeffrey A Loeb
Journal:  Epilepsia       Date:  2017-04-07       Impact factor: 5.864

Review 9.  Finding a better drug for epilepsy: the mTOR pathway as an antiepileptogenic target.

Authors:  Aristea S Galanopoulou; Jan A Gorter; Carlos Cepeda
Journal:  Epilepsia       Date:  2012-05-11       Impact factor: 5.864

10.  Pathological high frequency oscillations associate with increased GABA synaptic activity in pediatric epilepsy surgery patients.

Authors:  Carlos Cepeda; Simon Levinson; Hiroki Nariai; Vannah-Wila Yazon; Conny Tran; Joshua Barry; Katerina D Oikonomou; Harry V Vinters; Aria Fallah; Gary W Mathern; Joyce Y Wu
Journal:  Neurobiol Dis       Date:  2019-10-17       Impact factor: 5.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.